These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 25510219)

  • 1. Successful treatment of occult hepatitis B virus infection related membranous nephropathy after entecavir therapy.
    Xiong QF; Zhong YD; Hu ZL; Yang YF
    Acta Clin Belg; 2015 Jun; 70(3):223-5. PubMed ID: 25510219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complete remission of hepatitis B virus-related membranous nephropathy after entecavir monotherapy.
    Yang YF; Xiong QF; Zhao W; Zhong YD
    Clin Res Hepatol Gastroenterol; 2012 Oct; 36(5):e89-92. PubMed ID: 22572521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seroconversion of hepatitis B envelope antigen by entecavir in a child with hepatitis B virus-related membranous nephropathy.
    Igarashi T; Shimizu A; Igarashi T; Hanaoka K; Yoshizaki K; Shigemori T; Shimizu S; Komeichi H; Itoh Y
    J Nippon Med Sch; 2013; 80(5):387-95. PubMed ID: 24189358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful Use of Entecavir in Hepatitis B-associated Membranous Nephropathy.
    Mahajan V; D'Cruz S; Nada R; Sachdev A
    J Trop Pediatr; 2018 Jun; 64(3):249-252. PubMed ID: 28977667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complete remission of nephrotic syndrome of hepatitis B virus-associated membranous glomerulopathy after lamivudine monotherapy.
    Chuang TW; Hung CH; Huang SC; Lee CM
    J Formos Med Assoc; 2007 Oct; 106(10):869-73. PubMed ID: 17964968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis B virus-related membranous nephropathy treated with entecavir.
    Ikee R; Ishioka K; Oka M; Maesato K; Moriya H; Hidaka S; Ohtake T; Kobayashi S
    Nephrology (Carlton); 2010 Mar; 15(2):266. PubMed ID: 20470290
    [No Abstract]   [Full Text] [Related]  

  • 7. Efficacy of entecavir in treating hepatitis B virus-associated membranous nephropathy.
    Wang L; Xie B; Zheng Q; Xu L; Ye Z
    Rev Esp Enferm Dig; 2020 Nov; 112(11):843-849. PubMed ID: 33054304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Entecavir monotherapy is effective in suppressing hepatitis B virus after liver transplantation.
    Fung J; Cheung C; Chan SC; Yuen MF; Chok KS; Sharr W; Dai WC; Chan AC; Cheung TT; Tsang S; Lam B; Lai CL; Lo CM
    Gastroenterology; 2011 Oct; 141(4):1212-9. PubMed ID: 21762659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Membranous nephropathy associated with chronic hepatitis B occurring in a short period after acute hepatitis B virus infection.
    Nakahara K; Takahashi H; Okuse C; Shigefuku R; Yamada N; Murao M; Matsunaga K; Koike J; Yotsuyanagi H; Suzuki M; Kimura K; Itoh F
    Intern Med; 2010; 49(5):383-8. PubMed ID: 20190469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Entecavir versus lamivudine for hepatitis B prophylaxis in patients with haematological disease.
    Chen FW; Coyle L; Jones BE; Pattullo V
    Liver Int; 2013 Sep; 33(8):1203-10. PubMed ID: 23522150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful Treatment of Hepatitis B Virus-associated Membranous Nephropathy with Entecavir and Immunosuppressive Agents.
    Ochi A; Ishimura E; Ichii M; Ohno Y; Nakatani S; Kobayashi I; Shima H; Tsuda A; Shidara K; Mori K; Tamori A; Inaba M
    Nephrology (Carlton); 2014 Sep; 19(9):595-6. PubMed ID: 25156438
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment of hepatitis B virus-associated membranous glomerulonephritis with interferon alfa in a 7 year old boy].
    Steiss JO; Piske-Keyser K; Gröne HJ; Gortner L
    Klin Padiatr; 2000; 212(5):283-6. PubMed ID: 11048290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HBV-associated cryoglobulinemic vasculitis: remission after antiviral therapy with entecavir.
    Viganò M; Martin P; Cappelletti M; Fabrizi F
    Kidney Blood Press Res; 2014; 39(1):65-73. PubMed ID: 25011658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis B virus-associated glomerulonephritis in HBsAg serological-negative patients.
    Li D; Gao G; Jiang H; Tang Z; Yu Y; Zang G
    Eur J Gastroenterol Hepatol; 2015 Jan; 27(1):65-9. PubMed ID: 25386761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful withdrawal of antiviral treatment in kidney transplant recipients with chronic hepatitis B viral infection.
    Cho JH; Lim JH; Park GY; Kim JS; Kang YJ; Kwon O; Choi JY; Park SH; Kim YL; Kim HK; Huh S; Kim CD
    Transpl Infect Dis; 2014 Apr; 16(2):295-303. PubMed ID: 24628837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative hepatitis B surface antigen levels in patients with chronic hepatitis B after 2 years of entecavir treatment.
    Fung J; Lai CL; Young J; Wong DK; Yuen J; Seto WK; Yuen MF
    Am J Gastroenterol; 2011 Oct; 106(10):1766-73. PubMed ID: 21826112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Entecavir 1mg versus combined lamivudine/adefovir dipivoxil in chronic HBV Egyptian patients resistant to LAM monotherapy, non-randomised controlled study.
    Maklad S; Doss W; El Din SS; Hassan K; Zeid AA
    Arab J Gastroenterol; 2014 Mar; 15(1):1-5. PubMed ID: 24630505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of sulodexide might be associated with inhibition of complement system in hepatitis B virus-associated membranous nephropathy: An inspiration from a pilot trial.
    Yang Y; Ma L; Wang C; Kong D; Wang Y; Mei C
    Eur J Intern Med; 2016 Jul; 32():96-104. PubMed ID: 27160380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis-B virus associated nephropathies: a clinicopathological study in 14 children.
    Ozdamar SO; Gucer S; Tinaztepe K
    Pediatr Nephrol; 2003 Jan; 18(1):23-8. PubMed ID: 12488986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of entecavir treatment for lamivudine-resistant hepatitis B over 3 years: histological improvement or entecavir resistance?
    Suzuki Y; Suzuki F; Kawamura Y; Yatsuji H; Sezaki H; Hosaka T; Akuta N; Kobayashi M; Saitoh S; Arase Y; Ikeda K; Kobayashi M; Miyakawa Y; Kumada H
    J Gastroenterol Hepatol; 2009 Mar; 24(3):429-35. PubMed ID: 19226381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.